Vincamine - 98%, high purity , CAS No.1617-90-9, Allosteric modulator of M 1 receptor;Allosteric modulator of M 2 receptor;Allosteric modulator of M 3 receptor;Allosteric modulator of M 4 receptor

Item Number
V107385
Grouped product items
SKUSizeAvailabilityPrice Qty
V107385-250mg
250mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$39.90
V107385-1g
1g
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$79.90
V107385-5g
5g
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$266.90
V107385-25g
25g
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,059.90

Basic Description

SynonymsHMS2095H04 | C09251 | DTXSID9040134 | Methyl vincaminate | Oxybral | Tox21_111342_1 | Tripervan | Vincamina [DCIT] | VINCAMINE [MART.] | Anasclerol (base) | Equipur | KS-5179 | Vincamina | Cetal retard | HMS3712H04 | methyl (15S,17S,19S)-15-ethyl-17-hydro
Specifications & PurityMoligand™, ≥98%
Storage TempStore at 2-8°C
Shipped InWet ice
GradeMoligand™
Action TypeALLOSTERIC MODULATOR
Mechanism of actionAllosteric modulator of M 1 receptor;Allosteric modulator of M 2 receptor;Allosteric modulator of M 3 receptor;Allosteric modulator of M 4 receptor
Product Description

Vincamine is a monoterpenoid indole alkaloid extracted from the Madagascar periwinkle. Vincamine is a peripheral vasodilator and exerts a selective vasoregulator action on the brain microcapilar circulation. Vincamine is a GPR40 agonist and acts as a β-cell protector by ameliorating β-cell dysfunction and promoting glucose-stimulated insulin secretion (GSIS). Vincamine improves glucose homeostasis in vivo, and has the potential for the type 2 diabetes mellitus (T2DM) research.

Product Properties

ALogP2.9

Associated Targets(Human)

CHRM3 Tclin Muscarinic acetylcholine receptor M3 (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
CHRM4 Tclin Muscarinic acetylcholine receptor M4 (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
CHRM2 Tclin Muscarinic acetylcholine receptor M2 (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
CHRM1 Tclin Muscarinic acetylcholine receptor M1 (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
F2 Tclin Thrombin (11687 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ESR1 Tclin Estrogen receptor alpha (17718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PGR Tclin Progesterone receptor (8562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM2 Tclin Muscarinic acetylcholine receptor M2 (10671 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR1A Tclin Serotonin 1a (5-HT1a) receptor (14969 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2A Tclin Alpha-2a adrenergic receptor (9450 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AR Tclin Androgen Receptor (11781 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM1 Tclin Muscarinic acetylcholine receptor M1 (12690 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD2 Tclin Dopamine D2 receptor (23596 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GABRA1 Tclin GABA receptor alpha-1 subunit (399 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAOA Tclin Monoamine oxidase A (11911 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CNR1 Tclin Cannabinoid CB1 receptor (20913 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD1 Tclin Dopamine D1 receptor (9720 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS1 Tclin Cyclooxygenase-1 (9233 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A2 Tclin Norepinephrine transporter (10102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A4 Tclin Serotonin transporter (12625 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1A Tclin Alpha-1a adrenergic receptor (8359 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH1 Tclin Histamine H1 receptor (7573 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRM1 Tclin Mu opioid receptor (19785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD3 Tclin Dopamine D3 receptor (14368 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGIR Tclin Prostanoid IP receptor (1280 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A3 Tclin Dopamine transporter (10535 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE3A Tclin Phosphodiesterase 3A (3309 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM4 Tclin Muscarinic acetylcholine receptor M4 (6041 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2B Tclin Serotonin 2b (5-HT2b) receptor (10323 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TBXA2R Tclin Thromboxane A2 receptor (5717 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CNR2 Tchem Cannabinoid CB2 receptor (16942 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE4A Tclin Phosphodiesterase 4A (1943 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA3 Tchem Adenosine A3 receptor (15931 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH3 Tclin Histamine H3 receptor (10389 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CXCR4 Tclin C-X-C chemokine receptor type 4 (3338 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDR Tclin Vascular endothelial growth factor receptor 2 (20924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCRTR2 Tclin Orexin receptor 2 (5902 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FPR1 Tchem Formyl peptide receptor 1 (1372 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCR8 Tchem C-C chemokine receptor type 8 (339 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GNAS Tbio Guanine nucleotide-binding protein G(s), subunit alpha (103405 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver microsomes (16955 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRLHR Tchem Prolactin-releasing peptide receptor (450 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLCO1B1 Tchem Solute carrier organic anion transporter family member 1B1 (2672 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ATAD5 Tbio ATPase family AAA domain-containing protein 5 (122566 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLCO1B3 Tchem Solute carrier organic anion transporter family member 1B3 (2517 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
B16 (5829 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Npsr1 Neuropeptide S receptor (260 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Gpr119 Glucose-dependent insulinotropic receptor (270 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BCHE Cholinesterase (8742 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SARS-CoV-2 (38078 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Names and Identifiers

IUPAC Name methyl (15S,17S,19S)-15-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18)-tetraene-17-carboxylate
INCHI InChI=1S/C21H26N2O3/c1-3-20-10-6-11-22-12-9-15-14-7-4-5-8-16(14)23(17(15)18(20)22)21(25,13-20)19(24)26-2/h4-5,7-8,18,25H,3,6,9-13H2,1-2H3/t18-,20+,21+/m1/s1
InChi Key RXPRRQLKFXBCSJ-GIVPXCGWSA-N
Canonical SMILES CCC12CCCN3C1C4=C(CC3)C5=CC=CC=C5N4C(C2)(C(=O)OC)O
Isomeric SMILES CC[C@@]12CCCN3[C@@H]1C4=C(CC3)C5=CC=CC=C5N4[C@](C2)(C(=O)OC)O
WGK Germany 3
RTECS YY8575000
PubChem CID 15376
Molecular Weight 354.44
Beilstein 25(3/4)1252

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

6 results found

Lot NumberCertificate TypeDateItem
D2402505Certificate of AnalysisMar 09, 2024 V107385
D2402517Certificate of AnalysisMar 09, 2024 V107385
D2402518Certificate of AnalysisMar 09, 2024 V107385
D2402519Certificate of AnalysisMar 09, 2024 V107385
C1813119Certificate of AnalysisJan 27, 2022 V107385
C1813120Certificate of AnalysisJan 27, 2022 V107385

Chemical and Physical Properties

Specific Rotation[α]43° (C=1,Pyridine)
Melt Point(°C)232°C

Safety and Hazards(GHS)

Pictogram(s) GHS07
Signal Warning
Hazard Statements

H302:Harmful if swallowed

Precautionary Statements

P501:Dispose of contents/container to ...

P264:Wash hands [and …] thoroughly after handling.

P270:Do not eat, drink or smoke when using this product.

P330:Rinse mouth.

P301+P317:IF SWALLOWED: Get medical help.

WGK Germany 3
RTECS YY8575000
Merck Index 9983

Related Documents

References

1. L Bezin,D Marcel,S Desgeorges,J F Pujol,D Weissmann.  (2000-04-14)  Singular subsets of locus coeruleus neurons may recover tyrosine hydroxylase phenotype transiently expressed during development..  Brain research. Molecular brain research,  76  ((2)): (275-281).  [PMID:10762702]
2. S Caccamese,G Principato.  (2000-10-24)  Separation of the four pairs of enantiomers of vincamine alkaloids by enantioselective high-performance liquid chromatography..  Journal of chromatography. A,  893  ((1)): (47-54).  [PMID:11043586]
3. S Caccamese,G Principato,R Jokela,A Tolvanen,D Din Belle.  (2001-12-18)  Chiral HPLC separation and CD spectra of the enantiomers of the alkaloid tacamonine and related compounds..  Chirality,  13  ((10)): (691-693).  [PMID:11746802]
4. Y Kitazawa.  (2002-01-23)  [Open-angle glaucoma clinical presentation and management]..  Nippon Ganka Gakkai zasshi,  105  ((12)): (828-842).  [PMID:11802456]
5. Ying-Ping Juan,Tung-Hu Tsai.  (2005-09-01)  Measurement and pharmacokinetics of vincamine in rat blood and brain using microdialysis..  Journal of chromatography. A,  1088  ((1-2)): (146-151).  [PMID:16130744]
6. Adám Vas,Balázs Gulyás.  (2005-09-15)  Eburnamine derivatives and the brain..  Medicinal research reviews,  25  ((6)): (737-757).  [PMID:16158388]
7. Li Di,Edward H Kerns,Hong Chen,Susan L Petusky.  (2005-10-20)  Development and application of an automated solution stability assay for drug discovery..  Journal of biomolecular screening,  11  ((1)): (40-47).  [PMID:16234336]
8. Dylan B England,Albert Padwa.  (2007-07-31)  Synthesis of (+/-)-3H-epivincamine via a Rh(II)-triggered cyclization/cycloaddition cascade..  Organic letters,  ((17)): (3249-3252).  [PMID:17658832]
9. Amr Mohamed Beltagi.  (2008-12-02)  Development and validation of an adsorptive stripping voltammetric method for the quantification of vincamine in its formulations and human serum using a Nujol-based carbon paste electrode..  Chemical & pharmaceutical bulletin,  56  ((12)): (1651-1657).  [PMID:19043234]
10. Thomas Sycha,Clemens Vass,Oliver Findl,Peter Bauer,Ilse Groke,Leopold Schmetterer,Hans-Georg Eichler.  (2010-02-19)  WITHDRAWN: Interventions for normal tension glaucoma..  The Cochrane database of systematic reviews,    ((2)(2)): (CD002222-CD002222).  [PMID:20166063]
11. Koichiro Koyama,Yusuke Hirasawa,Takahiro Hosoya,Teh Chin Hoe,Kit-Lam Chan,Hiroshi Morita.  (2010-06-26)  Alpneumines A-H, new anti-melanogenic indole alkaloids from Alstonia pneumatophora..  Bioorganic & medicinal chemistry,  18  ((12)): (4415-4421).  [PMID:20576577]
12. Hong Yin,Yu-Hong Sun.  (2011-02-15)  Vincamine-producing endophytic fungus isolated from Vinca minor..  Phytomedicine : international journal of phytotherapy and phytopharmacology,  18  ((8-9)): (802-805).  [PMID:21315568]
13. Entai Hou,Yingjuan Wang,Duowei Li,Na Li,Hongdong Chen,Huaiyu Bu.  (2011-07-19)  [Tissue culture of Vinca minor and determination of vincamine]..  Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica,  36  ((7)): (823-827).  [PMID:21761716]
14. Dritan Hasa,Beatrice Perissutti,Cinzia Cepek,Sunil Bhardwaj,Elvio Carlino,Mario Grassi,Sergio Invernizzi,Dario Voinovich.  (2012-11-29)  Drug salt formation via mechanochemistry: the case study of vincamine..  Molecular pharmaceutics,  10  ((1)): (211-224).  [PMID:23186380]
15. Amir Akhgari,Into Laakso,Tuulikki Seppänen-Laakso,Teijo Yrjönen,Heikki Vuorela,Kirsi-Marja Oksman-Caldentey,Heiko Rischer.  (2015-06-23)  Determination of terpenoid indole alkaloids in hairy roots of Rhazya stricta (Apocynaceae) by GC-MS..  Phytochemical analysis : PCA,  26  ((5)): (331-338).  [PMID:26095837]
16. Takashi Matsumoto,Yousuke Matsubara,Yasuharu Mizuhara,Kyoji Sekiguchi,Junichi Koseki,Kazuaki Tsuchiya,Hiroaki Nishimura,Junko Watanabe,Atsushi Kaneko,Kazuya Maemura,Tomohisa Hattori,Yoshio Kase.  (2015-10-06)  Plasma Pharmacokinetics of Polyphenols in a Traditional Japanese Medicine, Jumihaidokuto, Which Suppresses Propionibacterium acnes-Induced Dermatitis in Rats..  Molecules (Basel, Switzerland),  20  ((10)): (18031-18046).  [PMID:26437394]
17. L Vereczkey.  (1985-04-01)  Pharmacokinetics and metabolism of vincamine and related compounds..  European journal of drug metabolism and pharmacokinetics,  10  ((2)): (89-103).  [PMID:3899662]
18. Mazák Károly,József Vámos,András Nemes,Akos Rácz,Béla Noszál.  (2003-07-02)  Lipophilicity of vinpocetine and related compounds characterized by reversed-phase thin-layer chromatography..  Journal of chromatography. A,  996  ((1-2)): (195-203).  [PMID:12830921]
19. T Sycha,C Vass,O Findl,P Bauer,I Groke,L Schmetterer,H Eichler.  (2003-10-30)  Interventions for normal tension glaucoma..  The Cochrane database of systematic reviews,  (4)  ((4)): (CD002222-CD002222).  [PMID:14583947]
20. Laurent Bezin,Catherine Ortemann,Michaël Ogier,Bernadette Astier,Jean-François Pujol,Bernard Renaud,Laura Lambas-Señas.  (2004-11-30)  Enhanced tail pinch-induced activation of catecholamine metabolism in the pericerulean area of RU 24722-treated rats..  Brain research,  1030  ((1)): (1-10).  [PMID:15567332]
21. Mostafa A M Shehata,Mohammad A El Sayed,Mohammad F El Tarras,Mohammad G El Bardicy.  (2005-05-24)  Stability-indicating methods for determination of vincamine in presence of its degradation product..  Journal of pharmaceutical and biomedical analysis,  38  ((1)): (72-78).  [PMID:15907622]
22. Mohammad G El-Bardicy,Hayam M Lotfy,Mohammad A El-Sayed,Mohammad F El-Tarras.  (2008-05-15)  Smart stability-indicating spectrophotometric methods for determination of binary mixtures without prior separation..  Journal of AOAC International,  91  ((2)): (299-310).  [PMID:18476341]
23. Yasser Shaker Ibrahim El-Saharty.  (2008-05-15)  Simultaneous determination of piracetam and vincamine by spectrophotometric and high-performance liquid chromatographic methods..  Journal of AOAC International,  91  ((2)): (311-321).  [PMID:18476342]
24. Abdel-Hasseb A Fayed.  (2009-11-11)  Brain trace element concentration of rats treated with the plant alkaloid, vincamine..  Biological trace element research,  136  ((3)): (314-319).  [PMID:19902161]
25. K Cambon,R Dos-Santos Coura,L Groc,A Carbon,D Weissmann,J P Changeux,J F Pujol,S Granon.  (2010-10-07)  Aggressive behavior during social interaction in mice is controlled by the modulation of tyrosine hydroxylase expression in the prefrontal cortex..  Neuroscience,  171  ((3)): (840-851).  [PMID:20923695]
26. Paul E Polak,Sergey Kalinin,David Braun,Anthony Sharp,Shao X Lin,Douglas L Feinstein.  (2012-02-01)  The vincamine derivative vindeburnol provides benefit in a mouse model of multiple sclerosis: effects on the Locus coeruleus..  Journal of neurochemistry,  121  ((2)): (206-216).  [PMID:22288774]

Solution Calculators